Literature DB >> 7916452

Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice.

Toshiaki Minami1, Rumiko Uda, Shigeko Horiguchi, Sciji Ito, Masayoshi Hyodo, Osamu Hayaishi.   

Abstract

We recently reported that intrathecal (i.t) administration of prostaglandin (PG) F2 alpha to conscious mice induced allodynia that was elicited by non-noxious brushing of the flanks. In the presents study, we demonstrate that i.t. administration of PGD2 and PGE2 to conscious mice also results in allodynia. Dose dependency of PGD2 for allodynia showed a skewed bell-shaped pattern (0.1 ng-2.5 micrograms/mouse), and the maximal allodynic effect was observed with 1.0 microgram at 15 min after intrathecal injection. PGD2-induced allodynia showed a time course and dose dependency similar to that induced by PGF2 alpha, but with lower scores. On the other hand, dose dependency of PGE2 for allodynia showed a bell-shaped pattern over a wide range of dosage from 10 fg to 2.0 micrograms/mouse. The maximal allodynic effect was observed with 0.01-0.1 microgram at 5 min after i.t. injection, and the response gradually decreased over the experimental period of 50 min. Intrathecally administered strychnine and the GABAA antagonist bicuculline also induced allodynia in conscious mice. The time courses of allodynia evoked by strychnine and bicuculline coincided with those by PGE2 and PGF2 alpha, respectively. PGE2-induced allodynia was dose-dependently relieved by the strychnine-sensitive glycine receptor agonist taurine, the NMDA receptor antagonist ketamine, and a high dose of the alpha 2-adrenergic agonist clonidine, but not by the GABAA agonist muscimol or by the GABAB agonist baclofen. In contrast, PGF2-induced allodynia was dramatically inhibited by clonidine and baclofen, but not by taurine, ketamine or muscimol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916452     DOI: 10.1016/0304-3959(94)90226-7

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  21 in total

1.  Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice.

Authors:  N Eguchi; T Minami; N Shirafuji; Y Kanaoka; T Tanaka; A Nagata; N Yoshida; Y Urade; S Ito; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase.

Authors:  A B Malmberg; E P Brandon; R L Idzerda; H Liu; G S McKnight; A I Basbaum
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

Review 3.  The spinal biology in humans and animals of pain states generated by persistent small afferent input.

Authors:  T L Yaksh; X Y Hua; I Kalcheva; N Nozaki-Taguchi; M Marsala
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Intracisternal or intrathecal glycine, taurine, or muscimol inhibit bicuculline-induced allodynia and thermal hyperalgesia in mice.

Authors:  Il-ok Lee; Eui-sung Lim
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

5.  Identification of mu-class glutathione transferases M2-2 and M3-3 as cytosolic prostaglandin E synthases in the human brain.

Authors:  C T Beuckmann; K Fujimori; Y Urade; O Hayaishi
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

6.  Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.

Authors:  T Minami; H Nakano; T Kobayashi; Y Sugimoto; F Ushikubi; A Ichikawa; S Narumiya; S Ito
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

7.  Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability.

Authors:  E Vasquez; K J Bär; A Ebersberger; B Klein; H Vanegas; H G Schaible
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

8.  Blockade by ONO-NT-012, a unique prostanoid analogue, of prostaglandin E2-induced allodynia in conscious mice.

Authors:  T Minami; I Nishihara; K Sakamoto; S Ito; M Hyodo; O Hayaishi
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

9.  Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain.

Authors:  Shigeo Hasegawa; Yuta Kohro; Miho Shiratori; Satoshi Ishii; Takao Shimizu; Makoto Tsuda; Kazuhide Inoue
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

10.  Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia.

Authors:  Cristina Tassorelli; Rosaria Greco; Giorgio Sandrini; Giuseppe Nappi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.